166480 — Corestemchemon Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Corestemchemon, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-22,384	-4,996	1,001	-17,672	-26,252
Depreciation
Amortisation
Non-Cash Items	17,647	-2,895	-2,859	2,675	7,949
Unusual Items
Other Non-Cash Items
Changes in Working Capital	5,696	-3,641	-11,161	-5,575	-7,583
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	4,466	-7,646	-8,420	-15,697	-21,118
Capital Expenditures	-5,019	-16,235	-9,915	-9,271	-23,038
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-29,759	-7,798	65,376	-26.6	-1,615
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-34,778	-24,034	55,462	-9,298	-24,653
Financing Cash Flow Items	16,864	1,104	541	970	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	61,157	3,717	-50,847	25,139	44,738
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	30,845	-27,963	-3,805	149	-970